Trial Profile
A retrospective study of fingolimod verses interferons or glatiramer acetate in treatment of patients with multiple sclerosis with a history of relapses
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2014
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary) ; Glatiramer acetate; Interferons
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 19 Sep 2014 New trial record